Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA Grants Regular (Full) Approval for IMBRUVICA® for Two Indications
FDA Grants Regular (Full) Approval for IMBRUVICA® for Two Indications
FDA Grants Regular (Full) Approval for IMBRUVICA® for Two Indications
Submitted by
admin
on July 28, 2014 - 1:28pm
Source:
Marketwatch
News Tags:
FDA
Imbruvica
chronic lymphocytic leukemia
Headline:
FDA Grants Regular (Full) Approval for IMBRUVICA® for Two Indications
Do Not Allow Advertisers to Use My Personal information
